What if it were possible to treat some cancers for less time, with tighter doses and fewer side effects, without losing effectiveness? This is one of the questions that gains weight in cancer research and that has focused part of the discussions of the recent congress of the European Society of Medical Oncology (ESMO), held in Madrid. The meeting has brought together specialists from around the world to share advances in new therapies, personali…
What if it were possible to treat some cancers for less time, with tighter doses and fewer side effects, without losing effectiveness? This is one of the questions that gains weight in cancer research and that has focused part of the discussions of the recent congress of the European Society of Medical Oncology (ESMO), held in Madrid. The meeting has brought together specialists from around the world to share advances in new therapies, personali…